Futures
Access hundreds of perpetual contracts
TradFi
Gold
One platform for global traditional assets
Options
Hot
Trade European-style vanilla options
Unified Account
Maximize your capital efficiency
Demo Trading
Introduction to Futures Trading
Learn the basics of futures trading
Futures Events
Join events to earn rewards
Demo Trading
Use virtual funds to practice risk-free trading
Launch
CandyDrop
Collect candies to earn airdrops
Launchpool
Quick staking, earn potential new tokens
HODLer Airdrop
Hold GT and get massive airdrops for free
Pre-IPOs
Unlock full access to global stock IPOs
Alpha Points
Trade on-chain assets and earn airdrops
Futures Points
Earn futures points and claim airdrop rewards
Robbins LLP Encourages SLNO Stockholders to Contact the Firm for Information About the Class Action
Robbins LLP is encouraging stockholders of Soleno Therapeutics, Inc. (NASDAQ: SLNO) to contact the firm regarding a class action lawsuit. The lawsuit alleges that Soleno Therapeutics misled investors about the safety and efficacy of its drug, DCCR, for Prader-Willi syndrome, citing concerns about fluid retention and adverse events. The complaint details stock declines following reports of an exposé on clinical trial issues, a patient death, and reduced DCCR launch trajectory due to community concerns.